文献速递脑血管病外科神经重症

自发性脑出血患者颅内压监测的疗效分析

Intracranial pressure monitoring in patients with spontaneous intracerebral hemorrhage.
PubMed 文献 · J Neurosurg · 2019-05-31

本研究基于ERICH研究(2010-2015)的回顾性数据,通过倾向性评分1:1匹配比较接受与未接受颅内压(ICP)监测的脑出血(ICH)患者。匹配队列各420例,结果显示两组90天和院内死亡率相似,但ICP监测组90天改良Rankin量表(mRS)偏移分析更差(p<0.001),且优秀和良好结局比例更低,而高渗治疗、血肿清除和感染率更高、住院时间更长。结论不支持ICH患者常规使用ICP监测。

要点

  • ICP监测未改善ICH患者90天死亡率,且与更差的90天mRS偏移相关(p<0.001)。
  • ICP监测组高渗治疗、血肿清除和感染率更高,住院时间更长。
  • 无脑室出血亚组中ICP监测与较低90天死亡率相关(p=0.041),但其他结局无差异。

核心结论

  • 研究结果不支持对ICH患者常规进行ICP监测。

研究设计与样本

  • 回顾性分析ERICH研究(2010-2015)数据,ICP监测组566例与未监测组2434例,经倾向性评分1:1匹配后各420例。
  • 主要结局为90天死亡率,次要结局包括院内死亡率、高渗治疗使用、血肿清除、住院时间、90天mRS、Barthel指数和健康相关生活质量(HRQoL)。

主要发现

  • 匹配队列中,ICP监测组与未监测组的90天死亡率和院内死亡率相似。
  • 90天mRS偏移分析显示未监测组更优(p<0.001);ICP监测组的优秀结局(mRS 0-1,p<0.001)、良好结局(mRS 0-2,p<0.001)、Barthel指数(p<0.001)、EQ-5D评分(p=0.026)和EQ-5D VAS评分(p=0.004)均更低。
  • ICP监测组的甘露醇使用(p<0.001)、高渗盐水使用(p<0.001)、血肿清除(p<0.001)和感染(p=0.001)比例更高,住院时间更长(p<0.001)。
  • 无脑室出血亚组匹配各111例,ICP监测组90天死亡率更低(p=0.041),但90天mRS偏移分析、Barthel指数和HRQoL指标组间相当。

临床怎么用

  • 不推荐对ICH患者常规进行ICP监测,应基于个体化评估谨慎选择。

局限性

  • 回顾性研究设计可能存在选择偏倚和混杂,尽管使用了倾向性评分匹配。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The utility of ICP monitoring and its benefit with respect to outcomes after ICH is unknown. The aim of this study was to compare intracerebral hemorrhage (ICH) outcomes in patients who underwent intracranial pressure (ICP) monitoring to those who were managed by care-guided imaging and/or clinical examination alone. METHODS: This was a retrospective analysis of data from the Ethnic/Racial variations of Intracerebral Hemorrhage (ERICH) study between 2010 and 2015. ICH patients who underwent ICP monitoring were propensity-score matched, in a 1:1 ratio, to those who did not undergo ICP monitoring. The primary outcome was 90-day mortality. Secondary outcomes were in-hospital mortality, hyperosmolar therapy use, ICH evacuation, length of hospital stay, and 90-day modified Rankin Scale (mRS) score, excellent outcome (mRS score 0-1), good outcome (mRS score 0-2), Barthel Index, and health-related quality of life (HRQoL; measured by EQ-5D and EQ-5D visual analog scale [VAS] scores). A secondary analysis for patients without intraventricular hemorrhage was performed. RESULTS: The ICP and no ICP monitoring cohorts comprised 566 and 2434 patients, respectively. The matched cohorts comprised 420 patients each. The 90-day and in-hospital mortality rates were similar between the matched cohorts. Shift analysis of 90-day mRS favored no ICP monitoring (p < 0.001). The rates of excellent (p < 0.001) and good (p < 0.001) outcome, Barthel Index (p < 0.001), EQ-5D score (p = 0.026), and EQ-5D VAS score (p = 0.004) at 90 days were lower in the matched ICP monitoring cohort. Rates of mannitol use (p < 0.001), hypertonic saline use (p < 0.001), ICH evacuation (p < 0.001), and infection (p = 0.001) were higher, and length of hospital stay (p < 0.001) was longer in the matched ICP monitoring cohort. In the secondary analysis, the matched cohorts comprised 111 patients each. ICP monitoring had a lower rate of 90-day mortality (p = 0.041). Shift analysis of 90-day mRS, Barthel Index, and HRQoL metrics were comparable between the matched cohorts. CONCLUSIONS: The findings of this study do not support the routine utilization of ICP monitoring in patients with ICH.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Chen CJ, Ding D, Ironside N, et al. Intracranial pressure monitoring in patients with spontaneous intracerebral hemorrhage. J Neurosurg. 2019. PMID: 31151113. doi:10.3171/2019.3.JNS19545

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。